MAGENTA genetic test alerts woman of her increased risk of developing ovarian cancer
Though there is still no early screening for ovarian cancer, genetic testing is one way to discover if an individual is at… View more
Noninvasive ovarian cancer biomarker detection via an optical nanosensor implant
Through their collaborative efforts, Tina’s Wish Researchers, Daniel Heller, PhD, MSKCC, Ryan Williams, PhD, MSKCC and Douglas Levine, NYU Langone Medical Center… View more
Repurposing existing FDA-approved inhibitors may provide new treatment approach for ovarian cancer
“Wistar researchers have found rationale for repurposing a class of antitumor compounds called HDAC inhibitors, already approved by the FDA for the… View more
Living with ovarian cancer as a chronic disease — and celebrating milestones
Joan Janssen, an ovarian cancer patient at Dana-Farber, speaks about the development of targeted therapies and how she is using them to… View more
NEW BLOOD TEST DEVELOPED TO DIAGNOSE OVARIAN CANCER
Investigators from Brigham and Women’s Hospital and Dana-Farber Cancer Institute, including Tina’s Wish researchers, Dipanjan Chowdhury, PhD, and Kevin Elias, MD, are… View more
OVARIAN CANCER MAY ACTUALLY ARISE IN FALLOPIAN TUBES
A preliminary study of ovarian cancer finds that in most cases it actually arises in the Fallopian tubes. If confirmed, the study could… View more